EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Measuring the Utility of Prenatal Exome Sequencing Using the Clinician‐Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study

Robin Z Hayeems iD, Stephanie Luca, Bowen Xiao iD, David Chitayat iD, Erin Mathews iD, Sankavi Mohanathas, Christie Boswell-Patterson, Kym M Boycott iD, Joanna Lazier iD, Patricia Silva-Roy, Courtney Kiss, Maggie Campbell und 9 weitere

Prenatal Diagnosis · 11.11.2026

DOI: 10.1002/pd.70306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 11.11.2026. Verfasst von Robin Z Hayeems und 20 weiteren Autor:innen. Beteiligte Einrichtung: Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Academic Health Science Center Alternative Funding Plan Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the diagnostic and clinical utility of prenatal exome sequencing (ES) in a cohort of pregnancies using the Clinician‐reported Genetic testing Utility InDEx for Prenatal Care (C‐GUIDE Prenatal).

Methods

Cases that met criteria for prenatal ES in Ontario, Canada were identified in 5 clinics. Clinicians assessed the utility of ES using C‐GUIDE Prenatal, a clinician‐reported measure of how genetic testing informs pregnancy and neonatal management. Case characteristics were summarized descriptively. C‐GUIDE Prenatal total scores were calculated and regressed against clinically important variables using generalised estimating equations.

Results

Among 115 cases, the diagnostic yield was 41.7%. The mean C‐GUIDE Prenatal score was 9.48 (SD 11.51). Compared with negative results, informative positive results were associated with an increase in C‐GUIDE Prenatal score of 17.6 ( p < 0.001). Compared to meeting one criterion for ES, meeting ≥ 3 criteria was associated with an increase in C‐GUIDE Prenatal score of 3.8 ( p < 0.05). Compared with pregnancies that were not ongoing at result disclosure, ongoing pregnancy was associated with an increase in the C‐GUIDE Prenatal score of 2.8 ( p < 0.001).

Conclusion

Findings address a knowledge gap in the clinical value evidence base that informs policy and funding decision‐making for prenatal genetic testing.

Schlagwörter

Stichwörter der Autor:innen

cohortexome sequencingfetusgenetic testingmedicineobstetricspregnancyprenatal careprenatal diagnosisretrospective cohort study

Autor:innen und Institutionen

  • Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Sinai Health System, Toronto, Ontario, Canada.
  • Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Prenatal Screening Ontario, Better Outcomes Registry and Network (BORN) Ontario, Ottawa, Ontario, Canada.
  • Kingston Health Sciences Centre, Kingston, Ontario, Canada.

ORCID-Profile: Robin Z Hayeems, Bowen Xiao, David Chitayat, Erin Mathews, Kym M Boycott, Joanna Lazier, Kalene van Engelen, Pierre Sinajon, Elaine S Goh, Andrea Guerin, Tugce B Balci, Wendy J Ungar, Christine M Armour

Förderung

  • The Academic Health Science Center Alternative Funding Plan Innovation Fund

Zitieren

APA

Hayeems, R. Z., Luca, S., Xiao, B., Chitayat, D., Mathews, E., Mohanathas, S., Boswell-Patterson, C., Boycott, K. M., Lazier, J., Silva-Roy, P., Kiss, C., Campbell, M., Nevay, D. L., Dinchong, R., van Engelen, K., Sinajon, P., Goh, E. S., Guerin, A., Balci, T. B., …, & Armour, C. M. (2026). Measuring the Utility of Prenatal Exome Sequencing Using the Clinician‐Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study. Prenatal Diagnosis. https://doi.org/10.1002/pd.70306

Vancouver

Hayeems RZ, Luca S, Xiao B, Chitayat D, Mathews E, Mohanathas S, et al. Measuring the Utility of Prenatal Exome Sequencing Using the Clinician‐Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study. Prenatal Diagnosis. 2026. doi:10.1002/pd.70306

BibTeX
@article{Hayeems2026,
  author = {Hayeems, Robin Z and Luca, Stephanie and Xiao, Bowen and Chitayat, David and Mathews, Erin and Mohanathas, Sankavi and Boswell-Patterson, Christie and Boycott, Kym M and Lazier, Joanna and Silva-Roy, Patricia and Kiss, Courtney and Campbell, Maggie and Nevay, Dayna-Lynn and Dinchong, Rachelle and van Engelen, Kalene and Sinajon, Pierre and Goh, Elaine S and Guerin, Andrea and Balci, Tugce B and Ungar, Wendy J and Armour, Christine M},
  title = {Measuring the Utility of Prenatal Exome Sequencing Using the Clinician‐Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70306}
}
Kostenlos starten →